AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - October 11, 2022 Category: Cancer & Oncology Authors: M.I. Strecker K. Wlotzka F. Strassheimer B. Roller G. Ludmirski S. K önig J. R öder C. Opitz T. Alekseeva J. Reul L. Sevenich T. Tonn W.S. Wels J.P. Steinbach C.J. Buchholz M.C. Burger Source Type: research